Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic flat-panel X-ray imaging in COPD patients treated with tiotropium/olodaterol
jRCTs032210543Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tiotropium + olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Primary endpoint: Rate of change in lung surface area. Started Aug 2022; status: active, not recruiting.
02
Drugs
tiotropium + olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCTs032210543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs032210543.